Jul 28, 2025 08:01AM
Jul 28, 2025 08:01AM
Jun 24, 2025 08:18AM
Jun 24, 2025 08:15AM
Jun 5, 2025 09:03AM
Jun 5, 2025 08:04AM
Jun 5, 2025 08:04AM MAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung Cancer
Apr 1, 2025 08:32AM
Apr 1, 2025 08:30AM
Mar 19, 2025 11:01AM
Mar 19, 2025 11:00AM
Feb 27, 2025 08:51AM
Feb 26, 2025 08:48AM
Feb 26, 2025 08:47AM MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer
Feb 4, 2025 08:51AM
Feb 4, 2025 08:51AM
Jan 7, 2025 09:12AM
Jan 7, 2025 09:12AM
Dec 16, 2024 08:39AM
Dec 16, 2024 08:37AM
Jun 7, 2024 12:32PM MAIA Biotechnology's (MAIA) Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
Jun 7, 2024 12:31PM
Apr 5, 2024 08:01AM
Mar 7, 2024 09:45AM
Feb 7, 2024 08:01AM
Jan 17, 2024 09:02AM
Jan 17, 2024 09:00AM
Nov 17, 2023 09:01AM MAIA Biotechnology (MAIA) Receives FDA Orphan Drug Designation For THIO
Nov 17, 2023 09:00AM
Nov 10, 2023 07:01AM
Nov 10, 2023 07:01AM
Nov 7, 2023 08:15AM
Oct 10, 2023 11:15AM
Oct 3, 2023 08:01AM
Oct 3, 2023 08:01AM MAIA Biotechnology Announces FDA Clearance of IND Application for THIO, a First-in-Class Telomere Targeting Agent for the Treatment of Non-Small Cell Lung Cancer
Apr 18, 2023 08:52AM
Apr 18, 2023 08:52AM
Mar 24, 2023 04:30PM
Feb 21, 2023 06:07PM
Feb 13, 2023 08:00AM
Feb 13, 2023 08:00AM
Dec 20, 2022 08:00AM MAIA Biotechnology Holds Successful Pre-IND Meeting with FDA for Planned US Expansion of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
Nov 15, 2022 08:02AM
Nov 15, 2022 08:00AM
Sep 29, 2022 09:01AM
Aug 22, 2022 08:00AM
Aug 2, 2022 08:00AM
Apr 11, 2022 06:08AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All